List of bibliographic references
Number of relevant bibliographic references: 5.
| Ident. | Authors (with country if any) | Title |
|---|
| 000261 (2017) |
Paolo A. Ascierto [Italie] ; Michele Del Vecchio [Italie] ; Caroline Robert [France] ; Andrzej Mackiewicz [Pologne] ; Vanna Chiarion-Sileni [Italie] ; Ana Arance [Espagne] ; Céleste Lebbé [France] ; Lars Bastholt [Danemark] ; Omid Hamid [États-Unis] ; Piotr Rutkowski [Pologne] ; Catriona Mcneil [Australie] ; Claus Garbe [Allemagne] ; Carmen Loquai [Allemagne] ; Brigitte Dreno [France] ; Luc Thomas [France] ; Jean-Jacques Grob [France] ; Gabriella Liszkay [Hongrie] ; Marta Nyakas [Norvège] ; Ralf Gutzmer [Allemagne] ; Joanna Pikiel [Pologne] ; Florent Grange [France] ; Christoph Hoeller [Autriche] ; Virginia Ferraresi [Italie] ; Michael Smylie [Canada] ; Dirk Schadendorf [Allemagne] ; Laurent Mortier [France] ; Inge Marie Svane [Danemark] ; Delphine Hennicken [États-Unis] ; Anila Qureshi [États-Unis] ; Michele Maio [Italie] | Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. |
| 000503 (2017) |
Reinhard Dummer [Suisse] ; Dirk Schadendorf [Allemagne] ; Paolo A. Ascierto [Italie] ; Ana Arance [Espagne] ; Caroline Dutriaux [France] ; Anna Maria Di Giacomo [Italie] ; Piotr Rutkowski [Pologne] ; Michele Del Vecchio [Italie] ; Ralf Gutzmer [Allemagne] ; Mario Mandala [Italie] ; Luc Thomas [France] ; Lev Demidov [Russie] ; Claus Garbe [Allemagne] ; David Hogg [Canada] ; Gabriella Liszkay [Hongrie] ; Paola Queirolo [Italie] ; Ernesto Wasserman [États-Unis] ; James Ford [États-Unis] ; Marine Weill [Suisse] ; L Andres Sirulnik [États-Unis] ; Valentine Jehl [Suisse] ; Viviana Boz N [États-Unis] ; Georgina V. Long [Australie] ; Keith Flaherty [États-Unis] | Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. |
| 000652 (2016) |
Reinhard Dummer [Suisse] ; Alexander Guminski [Australie] ; Ralf Gutzmer [Allemagne] ; Luc Dirix [Belgique] ; Karl D. Lewis [États-Unis] ; Patrick Combemale [France] ; Robert M. Herd [Royaume-Uni] ; Martin Kaatz [Allemagne] ; Carmen Loquai [Allemagne] ; Alexander J. Stratigos [Grèce] ; Hans-Joachim Schulze [Allemagne] ; Ruth Plummer [Royaume-Uni] ; Sven Gogov [Suisse] ; Celine Pallaud [Suisse] ; Tingting Yi [États-Unis] ; Manisha Mone [États-Unis] ; Anne Lynn S. Chang [États-Unis] ; Frank Cornélis [Belgique] ; Ragini Kudchadkar [Géorgie (pays)] ; Uwe Trefzer [Allemagne] ; John T. Lear [Royaume-Uni] ; Dalila Sellami [États-Unis] ; Michael R. Migden [États-Unis] | The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. |
| 000B12 (2015) |
Michael R. Migden [États-Unis] ; Alexander Guminski [Australie] ; Ralf Gutzmer [Allemagne] ; Luc Dirix [Belgique] ; Karl D. Lewis [États-Unis] ; Patrick Combemale [France] ; Robert M. Herd [Royaume-Uni] ; Ragini Kudchadkar [États-Unis] ; Uwe Trefzer [Allemagne] ; Sven Gogov [Suisse] ; Celine Pallaud [Suisse] ; Tingting Yi [États-Unis] ; Manisha Mone [États-Unis] ; Martin Kaatz [Allemagne] ; Carmen Loquai [Allemagne] ; Alexander J. Stratigos [Grèce] ; Hans-Joachim Schulze [Allemagne] ; Ruth Plummer [Royaume-Uni] ; Anne Lynn S. Chang [États-Unis] ; Frank Cornélis [Belgique] ; John T. Lear [Royaume-Uni] ; Dalila Sellami [États-Unis] ; Reinhard Dummer [Suisse] | Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. |
| 001853 (2012) |
Axel Hauschild [Allemagne] ; Jean-Jacques Grob [France] ; Lev V. Demidov [Russie] ; Thomas Jouary [France] ; Ralf Gutzmer [Allemagne] ; Michael Millward [Australie] ; Piotr Rutkowski [Pologne] ; Christian U. Blank [Pays-Bas] ; Wilson H. Jr Miller [Canada] ; Eckhart Kaempgen [Allemagne] ; Salvador Martin-Algarra [Espagne] ; Bogusiawa Karaszewska [Pologne] ; Cornelia Mauch [Allemagne] ; Vanna Chiarion-Sileni [Italie] ; Anne-Marie Martin [États-Unis] ; Suzanne Swann [États-Unis] ; Patricia Haney [États-Unis] ; Beloo Mirakhur [États-Unis] ; Mary E. Guckert [États-Unis] ; Vicki Goodman [États-Unis] ; Paul B. Chapman [États-Unis] | Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlledtrial |
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Aged |
| 4 | Female |
| 4 | Humans |
| 4 | Male |
| 4 | Middle Aged |
| 3 | Adult |
| 3 | Aged, 80 and over |
| 3 | Double-Blind Method |
| 3 | Survival Rate |
| 2 | Antineoplastic Agents (administration & dosage) |
| 2 | Antineoplastic Agents (adverse effects) |
| 2 | Biphenyl Compounds (administration & dosage) |
| 2 | Biphenyl Compounds (adverse effects) |
| 2 | Carcinoma, Basal Cell (drug therapy) |
| 2 | Follow-Up Studies |
| 2 | Melanoma (drug therapy) |
| 2 | Pyridines (administration & dosage) |
| 2 | Pyridines (adverse effects) |
| 2 | Skin Neoplasms (drug therapy) |
| 2 | Skin Neoplasms (pathology) |
| 2 | Treatment Outcome |
| 1 | Advanced stage |
| 1 | Alanine Transaminase (blood) |
| 1 | Antibodies, Monoclonal (administration & dosage) |
| 1 | Antibodies, Monoclonal (adverse effects) |
| 1 | Antineoplastic Agents (therapeutic use) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 1 | BRAF Gene |
| 1 | Benzimidazoles (administration & dosage) |
| 1 | Biphenyl Compounds (therapeutic use) |
| 1 | C-Onc gene |
| 1 | Carcinoma, Basal Cell (pathology) |
| 1 | Carcinoma, Basal Cell (radiotherapy) |
| 1 | Carcinoma, Basal Cell (secondary) |
| 1 | Carcinoma, Basal Cell (surgery) |
| 1 | Colitis (chemically induced) |
| 1 | Dacarbazine (administration & dosage) |
| 1 | Diarrhea (chemically induced) |
| 1 | Disease Progression |
| 1 | Disease-Free Survival |
| 1 | GTP Phosphohydrolases (genetics) |
| 1 | Hypophysitis (chemically induced) |
| 1 | Intention to Treat Analysis |
| 1 | Kaplan-Meier Estimate |
| 1 | Label |
| 1 | Malignant melanoma |
| 1 | Medicine |
| 1 | Melanoma (genetics) |
| 1 | Melanoma (pathology) |
| 1 | Melanoma (secondary) |
| 1 | Membrane Proteins (genetics) |
| 1 | Metastasis |
| 1 | Metastatic |
| 1 | Multicenter study |
| 1 | Mutation |
| 1 | Mutation (genetics) |
| 1 | Neoplasm Metastasis |
| 1 | Neoplasm Recurrence, Local (drug therapy) |
| 1 | Neoplasm Recurrence, Local (pathology) |
| 1 | Neoplasm Recurrence, Local (radiotherapy) |
| 1 | Neoplasm Recurrence, Local (surgery) |
| 1 | Neoplasm Staging |
| 1 | Phase |
| 1 | Prognosis |
| 1 | Protooncogene |
| 1 | Pyridines (therapeutic use) |
| 1 | Randomization |
| 1 | Skin Neoplasms (radiotherapy) |
| 1 | Skin Neoplasms (surgery) |
| 1 | Smoothened Receptor (antagonists & inhibitors) |
| 1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Ralf Gutzmer"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Ralf Gutzmer" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Ralf Gutzmer
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
